Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07235046 · ClinicalTrials.gov registry record · Phase 2
A Study of DII235 in Adults With Elevated Lipoprotein(a)
A Phase 2 study of Lipoprotein Disorder, sponsored by Novartis Pharmaceuticals.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 20
- Study locations
NCT07235046 is a Phase 2 study of Lipoprotein Disorder that is actively recruiting participants, run by Novartis Pharmaceuticals. The registered enrollment target is 200 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT07235046, a Phase 2 study of Lipoprotein Disorder, is actively recruiting participants, sponsored by Novartis Pharmaceuticals.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
Conditions Studied
Interventions
- DRUG Saline
- DRUG DII235
Study Locations (20)
Florida
- Excel Medical Clinical Trials LLC - Boca Raton
- Zenith Clinical Research - Hollywood
- Jacksonville Center for Clinical Research - Jacksonville
- Flourish Res Acq LLC North Miami - Miami
- Inpatient Research Clinical LLC - Miami Lakes
- Inpatient Research Clinical LLC - Miami Lakes
- Ocala Cardiovascular Research - Ocala
- SEC Clinical Research - Pensacola
- Cardiology Partners Clinical Research Institute - Wellington
Alabama
- Parkway Medical Center - Birmingham
- Heart Center Research Llc - Huntsville
California
- National Heart Institute - Beverly Hills
- Alliance Clinical - Canoga Park
Louisiana
- CV Ins of the South - Lafayette
- Monroe Research Llc - West Monroe
Arkansas
- Cardiology and Medicine Clinic PA - Little Rock
Georgia
- Atlanta Heart Specialists LLC - Tucker
Illinois
- AMR Chicago - Oak Brook
Kansas
- Alliance for Multispecialty Research - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2028-09-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07235046
The ClinicalTrials.gov registry entry for NCT07235046 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lipoprotein Disorder appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT07235046 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT07235046 about?
NCT07235046 is a clinical study titled "A Study of DII235 in Adults With Elevated Lipoprotein(a)". The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
What is the current status of trial NCT07235046?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2025-12-05. Estimated completion is 2028-09-08.
What conditions does trial NCT07235046 study?
This clinical trial studies the following conditions: Lipoprotein Disorder.
What interventions are being tested in trial NCT07235046?
The interventions under investigation include: Saline (DRUG), DII235 (DRUG).
Who is sponsoring clinical trial NCT07235046?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07235046 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lipoprotein Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.